Irina V. Balyasnikova

Northwestern University — United States

Medicine · Health Sciences

41h-index5.6kcitations244works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(48), Glioma Diagnosis and Treatment(33), Monoclonal and Polyclonal Antibodies Research(29), Immune cells in cancer(29), RNA Interference and Gene Delivery(28)

Publications243 total

The Transcranial Cisternal Port (TCP): A Novel Technique for Repetitive Intrathecal Delivery in Mice
2025Open Access
DDDR-26. Preclinical evaluation of first-in-class PROTAC survivin degrader HMAK101 for radiosensitization of CNS malignancies
Neuro-Oncology·2025Open Access
EXTH-135. Intrathecally delivered T cells precomplexed with a Bispecific T-cell Engager target CNS tumors
Neuro-Oncology·2025Open Access
IMMU-73. A Novel Tri-Specific T Cell Engager Improves <i>In Vivo</i> Outcomes by Addressing Glioblastoma Heterogeneity
Neuro-Oncology·2025Open Access
Role of Serum Stability and Lipoprotein Interactions in Lipid Structure–Tumor Accumulation Relationship
ACS Nano·2025· 1 cited
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models
Journal for ImmunoTherapy of Cancer·2025Open Access
Preclinical Evaluation of First-in-Class PROTAC Survivin Degrader HMAK101 for Radiosensitization for GBM, DIPG and Brain Metastases
International Journal of Radiation Oncology*Biology*Physics·2025
Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms
Clinical Cancer Research·2025· 1 citedOpen Access
Microglial Fructose Metabolism Is Essential for Glioblastoma Growth
2025Open Access
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas
Acta Neuropathologica Communications·2025· 2 citedOpen Access
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas
2024Open Access
IMMU-19. PRECLINICAL THERAPEUTIC ACTIVITY AND PET IMAGING OF STING AGONIST 8803 IN GLIOBLASTOMA
Neuro-Oncology·2024· 1 citedOpen Access
640 TRP-1 reactive BiTE proteins and CAR T-cells engage different anti-tumor immune mechanisms
Journal of Investigative Dermatology·2024Open Access
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
Journal of Clinical Investigation·2024· 36 citedOpen Access
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions
ACS Nano·2024· 59 citedOpen Access
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
Cancers·2023· 12 citedOpen Access
Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2
Cell Death and Disease·2023· 10 citedOpen Access
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
Journal of Clinical Investigation·2023· 17 citedOpen Access
Cyanine lipids promote the shedding of extracellular vesicles from cell membranes
Precision Nanomedicine·2023· 1 citedOpen Access
In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies
OncoImmunology·2023· 7 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Maciej S. Lesniak(23), Sergei M. Danilov(15), Atique U. Ahmed(10), Yu Han(9), Yu Han(7), Karen S. Aboody(7), Lingjiao Zhang(7), Μαρκέλλα Ζαννίκου(6), Catalina Lee-Chang(6), Jason Miska(6), Craig Horbinski(5), Deepak Kanojia(5), Ramin A. Morshed(5), Dou Yu(5), Ronald F. Albrecht(5), Stephen Gottschalk(4), Ting Xiao(4), Adam M. Sonabend(4), Katarzyna C. Pituch(4), Gina Li(4)